This trial is testing a new retinal prothesis for safety and performance in subjects with dry age related macular degeneration.
- Age-Related Macular Degeneration (AMD)
0 Primary · 4 Secondary · Reporting Duration: 3, 6, 9, 12, 18, 24 and 36 months after implantation
1 Treatment Group
1 of 1
5 Total Participants · 1 Treatment Group
Primary Treatment: PRIMA · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 37 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is there still room for potential participants to join this research?
"As per clinicaltrials.gov, this experiment is currently seeking participants. First posted on April 26th 2018 and last updated June 6th 2022." - Anonymous Online Contributor
How many participants are currently enrolled in this experiment?
"This study necessitates that 5 eligible participants enroll in the trial. Potential patients can take part from various locations such as Bascom Palmer Eye Institute in Miami, Florida and Byers Eye Institute-Stanford University in Palo Alto, California." - Anonymous Online Contributor